Provista Diagnostics to Present at The 2016 BIO International Convention
24. Mai 2016 12:00 ET
|
Provista Diagnostics, Inc.
New York, NY, May 24, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at...
Provista Diagnostics Announces New Chief Financial Officer and Expands Commercial Team Expertise
06. April 2016 09:00 ET
|
Provista Diagnostics, Inc.
New York, April 06, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., a company developing and commercializing molecular diagnostic, prognostic and monitoring tests for cancers affecting women,...
Provista Diagnostics Closes $5.25 Million Financing
21. März 2016 09:00 ET
|
Provista Diagnostics, Inc.
New York, March 21, 2016 (GLOBE NEWSWIRE) -- NEW YORK, NY – March 21, 2016 - Provista Diagnostics, Inc., a company developing and commercializing proteomic-based diagnostic, prognostic and...
Provista Diagnostics to Present at The 18th Annual BIO CEO & Investor Conference
08. Februar 2016 11:31 ET
|
Provista Diagnostics, Inc.
New York, NY, Feb. 08, 2016 (GLOBE NEWSWIRE) -- NEW YORK, NY – February 8, 2016 – Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will...
Provista Diagnostics to Present at The 18th Annual BIO CEO & Investor Conference
08. Februar 2016 10:48 ET
|
Provista Diagnostics, Inc.
New York, NY, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at the...
Provista Diagnostics to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostics Forum
18. November 2015 16:19 ET
|
Provista Diagnostics, Inc.
New York, NY, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at the...
Provista Diagnostics Offers Hope for the Early Detection of Breast Cancer in Women with Dense Breasts
29. September 2015 15:52 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc. today announced that the data from two prospective, randomized, multi-center clinical studies, evaluating a novel...
Provista Diagnostics to Present New Clinical Data at the 2015 American Society of Clinical Oncology Breast Cancer Symposium
23. September 2015 14:00 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary...
Provista Diagnostics Announces Reelection of the Company's Board of Directors
21. September 2015 14:04 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company developing and commercializing a new generation of proprietary blood-based...
Provista Diagnostics Announces the Closing of $6.0 Million Financing
04. August 2015 15:20 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, Aug. 4, 2015 (GLOBE NEWSWIRE) -- August 4, 2015: Provista Diagnostics, Inc., a privately held molecular diagnostics company headquartered in New York, today announced the closing of $6.0...